Xlife Sciences AG (SWX:XLS)
Switzerland · Delayed Price · Currency is CHF 20.50
-0.10 (-0.49%)
Last updated: May 13, 2026, 3:11 PM CET
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 118.81 million as of May 13, 2026. Its market cap has decreased by -20.41% in one year.
Market Cap
118.81M
Enterprise Value
263.59M
Revenue
275.31K
Ranking
n/a
PE Ratio
n/a
Stock Price
20.50
Market Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 118.81M, a decrease of -50.59%. That is a compound annual growth rate of -15.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 118.81M | -16.60% |
| Dec 30, 2025 | 142.46M | -2.32% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
| Feb 10, 2022 | 240.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 6.02B |
| Idorsia | 978.36M |
| Basilea Pharmaceutica AG | 669.89M |
| Newron Pharmaceuticals | 272.20M |
| Santhera Pharmaceuticals Holding AG | 238.78M |
| BioVersys AG | 161.41M |
| Molecular Partners AG | 120.84M |
| MindMaze Therapeutics Holding | 56.46M |